Skip to Main Content

Paper Details

Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders.
Hepatology
4
2023
DC, Dyskeratosis congenita, Liver abnormality, Patients, TBD, TINF2, TINF2 -associated DC, TINF2 DC, bone marrow failure, dyskeratosis congenita, hepatic abnormalities, liver abnormality, liver disease, mucocutaneous triad features, multisystem organ involvement, patients, portal hypertension, pulmonary and/or vascular disease, pulmonary or vascular disease, telomere biology disorders, telomeres
Author NameAffiliation
Sharon A SavageClinical Genetics Branch, National Cancer Institute, National Institutes of Health
Sharon A SavageClinical Genetics Branch, National Cancer Institute, National Institutes of Health
Christopher KohNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Christopher KohNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Theo HellerNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Theo HellerNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
  • 1 - 6

Datasets

Release 1.2